Clinical Trials Logo

Esophagectomy clinical trials

View clinical trials related to Esophagectomy.

Filter by:
  • Completed  
  • Page 1

NCT ID: NCT05604950 Completed - Clinical trials for Esophageal Squamous Cell Carcinoma

Surgery Versus Non-surgical Treatment for Esophageal Squamous Cell Carcinoma in Patients Older Than 70 Years

Start date: January 1, 2009
Phase:
Study type: Observational [Patient Registry]

To determine whether older patients who underwent esophagectomy had better outcome survival than those who were non-surgically treated.

NCT ID: NCT04597398 Completed - Esophagectomy Clinical Trials

Utility of the Evaluation of Blood Flow of the Remnant Esophagus in Esophagectomy With Pedicled Jejunum Reconstruction

Start date: April 1, 2012
Phase:
Study type: Observational

Pedicled jejunal flap can be utilized with various tips for esophageal reconstruction in patients with a history of gastrectomy, or those who have undergone synchronous esophagogastrectomy, although the rate of anastomosis leakage is high with this technique. Therefore, in the current study, we considered the utility of the evaluation of blood flow of the remnant esophagus with indocyanine green in setting the anastomosis site. We included 50 patients who underwent radical esophagectomy with pedicled jejunal flap between April 2012 and June 2020. From June 2019, the blood flow of not only the pedicled jejunum, but also the remnant esophagus were evaluated in order to set the anastomosis site of the latter because the color was not definitive criteria for judging in surgery on the remnant esophagus. Usually, the second and third jejunal vessels are transected, and if the jejunal flap cannot reach to the anastomosis point, we actively transect the marginal vessels in order to stretch the jejunal flap. Microvascular anastomosis between the jejunal branches (the second) and the internal thoracic vessels is usually made, and the anastomosis site is set at the part of the esophagus that is well-dyed with indocyanine green. A total of 39 patients underwent the procedure prior to June 2019 ( Group A), and 11 patients underwent the procedure as of June 2019 (Group B). No significant difference was found in the patients' background, type of preoperative therapy, and presence or absence of ligation of marginal vessels and two-stage operation between the two groups. Group A had 16 cases of anastomosis leakage, while Group B only has one (P < 0.05). There were no cases of significant pedicled jejunum graft necrosis. Our findings demonstrate that the evaluation of the blood flow of the remnant esophagus during setting of the anastomosis site may decrease the rate of anastomosis.

NCT ID: NCT02158286 Completed - Esophagectomy Clinical Trials

Paracetamol Absorption Technique as a Method for Measuring Gastric Tube Outlet

Start date: January 2012
Phase: N/A
Study type: Observational

Retention of the gastric tube after esophagectomy is a clinically important problem, and there is a need of a simple method to evaluate emptying rate from the gastric tube after esophagectomy. Scintigraphy is the golden standard of measuring emptying rate from the gastric tube. In non-operated patients, paracetamol clearance technique have been widely used for measuring gastric emptying rate. There is no validation however if paracetamol clearance technique can be used for measuring emptying rate of the gastric tube. The investigators aim of this pilot- study is to validate paracetamol clearance technique to scintigraphy for measuring emptying rate from the gastric tube and to evaluate if there is a correlation between symptoms of retention and quality of life with the emptying rate.

NCT ID: NCT01169051 Completed - Esophagectomy Clinical Trials

A Retrospective Analysis of Statin Use and Outcome After Thoracic Cancer Surgery

Start date: July 2010
Phase: N/A
Study type: Observational

There is data to support an association between impaired preoperative endothelial function and adverse postoperative outcome. This study will investigate the potential association between perioperative statin use and improved perioperative and long-term cancer outcome amongst thoracic surgery patients undergoing lung or esophageal resection.

NCT ID: NCT00827931 Completed - Clinical trials for Pancreaticoduodenectomy

Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery

Start date: September 2009
Phase: Phase 4
Study type: Interventional

Tranexamic acid has been shown to reduce postoperative blood losses and transfusion requirements in various types of major surgery (orthopedic surgery, spine surgery, cardiopulmonary bypass, liver resections, and gynecological cancers).The current trial is being conducted to compare the efficacy of tranexamic acid plus standard of care versus standard of care in reduction of blood loss in patients undergoing major abdominal surgeries.

NCT ID: NCT00708513 Completed - Hepatectomy Clinical Trials

Intraoperative Cell Saver Autotransfusion Use for Major Surgical Oncology Operations.

Cellsaver
Start date: December 2003
Phase: N/A
Study type: Observational

The purpose of this study is to demonstrate the safety and benefit of auto-transfusion filtered blood in patients undergoing major surgical oncology procedures.

NCT ID: NCT00585624 Completed - Clinical trials for Pancreaticoduodenectomy

Preoperative Nutritional Support in Esophagectomy or Pancreaticoduodenectomy

Start date: April 2007
Phase: N/A
Study type: Interventional

We are proposing to evaluate the benefit of preoperative nutritional support with Impact Advanced Recovery in the most vulnerable group of elective gastrointestinal surgery patients who may experience a complication, esophagus and pancreas resections, and hypothesize that oral supplementation with 3 servings (0.75 L) Impact Advanced Recovery will reduce postoperative stay by 10-20% and reduce the incidence of major complications by 25%.

NCT ID: NCT00420017 Completed - Atrial Fibrillation Clinical Trials

Prevention of Atrial Fibrillation Following Esophagectomy

Start date: September 2005
Phase: Phase 4
Study type: Interventional

The investigators hypothesize that the medication amiodarone decreases the incidence of atrial fibrillation (AF) following esophagectomy surgery. Their specific aims are to: Determine the effectiveness of amiodarone for the prevention of AF following esophagectomy surgery; Determine the influence of the prevention of AF following esophagectomy surgery on post-surgical duration of stay in the Intensive Care Unit ICU)and duration of post-surgical hospital stay; and Determine the safety of amiodarone for the prevention of AF following esophagectomy surgery.